{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:45:46Z","timestamp":1761489946901},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151842","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T17:46:23Z","timestamp":1458236783000},"page":"e0151842","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immunological Characterization of Plant-Based HIV-1 Gag\/Dgp41 Virus-Like Particles"],"prefix":"10.1371","volume":"11","author":[{"given":"Sarah A.","family":"Kessans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia R.","family":"Meador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn","family":"Kilbourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda G.","family":"Hogue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Fromme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsafrir S.","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,3,17]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/MMBR.00020-07","article-title":"The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design","volume":"72","author":"M Montero","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/pro.2540","article-title":"Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV-1 gp41","volume":"23","author":"Z Gong","year":"2014","journal-title":"Protein Sci"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.4049\/jimmunol.166.10.6257","article-title":"Secretory IgA Specific for a Conserved Epitope on gp41 Envelope Glycoprotein Inhibits Epithelial Transcytosis of HIV-1","volume":"166","author":"A Alfsen","year":"2001","journal-title":"J Immunol"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/infdis\/jis183","article-title":"Transmembrane Domain Membrane Proximal External Region but Not Surface Unit-Directed Broadly Neutralizing HIV-1 Antibodies Can Restrict Dendritic Cell-Mediated HIV-1 Trans-infection","volume":"205","author":"M Sagar","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2006.11.035","article-title":"Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells","volume":"362","author":"A Magerus-Chatinet","year":"2007","journal-title":"Virology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2006.03.045","article-title":"Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649\u2013684), a mucosal subunit HIV\/AIDS vaccine candidate","volume":"24","author":"N Matoba","year":"2006","journal-title":"Vaccine"},{"issue":"37","key":"ref7","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1073\/pnas.0405297101","article-title":"A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs","volume":"101","author":"N Matoba","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"ref8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-2478(01)00263-2","article-title":"Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers","volume":"79","author":"K Broliden","year":"2001","journal-title":"Immunol Lett"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.4049\/jimmunol.165.9.5170","article-title":"Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells","volume":"165","author":"C Devito","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00002030-200102160-00026","article-title":"Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection","volume":"15","author":"R Kaul","year":"2001","journal-title":"Aids"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1097\/QAD.0b013e3283632ea1","article-title":"Secretory IgA specific for MPER can protect from HIV-1 infection in vitro","volume":"27","author":"F Benjelloun","year":"2013","journal-title":"AIDS"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/JVI.79.2.1252-1261.2005","article-title":"Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1","volume":"79","author":"MB Zwick","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/JVI.01272-09","article-title":"Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L","volume":"84","author":"AJ Hessell","year":"2010","journal-title":"Journal of virology"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2012.08.012","article-title":"Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies","volume":"37","author":"PD Kwong","year":"2012","journal-title":"Immunity"},{"issue":"7424","key":"ref15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"issue":"23","key":"ref16","doi-asserted-by":"crossref","first-page":"13910","DOI":"10.1128\/JVI.02083-14","article-title":"Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies","volume":"88","author":"M Bouvin-Pley","year":"2014","journal-title":"J Virol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"e27824","DOI":"10.1371\/journal.pone.0027824","article-title":"Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41","volume":"6","author":"SM Dennison","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20132","key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2012.05.005","article-title":"Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41","volume":"431","author":"C Pastori","year":"2012","journal-title":"Virology"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"e55438","DOI":"10.1371\/journal.pone.0055438","article-title":"Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes","volume":"8","author":"G Leroux-Roels","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","article-title":"A Blueprint for HIV Vaccine Discovery","volume":"12","author":"DR Burton","year":"2012","journal-title":"Cell host & microbe"},{"issue":"6136","key":"ref21","doi-asserted-by":"crossref","first-page":"1232910","DOI":"10.1126\/science.1232910","article-title":"Accelerating next-generation vaccine development for global disease prevention","volume":"340","author":"WC Koff","year":"2013","journal-title":"Science"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"e1004073","DOI":"10.1371\/journal.ppat.1004073","article-title":"HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development","volume":"10","author":"L Verkoczy","year":"2014","journal-title":"PLoS Pathog"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.bbamem.2012.06.002","article-title":"Mechanism of membrane perturbation by the HIV-1 gp41 membrane-proximal external region and its modulation by cholesterol","volume":"1818","author":"A Ivankin","year":"2012","journal-title":"Biochimica et biophysica acta"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/JVI.06349-11","article-title":"Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane","volume":"86","author":"M Montero","year":"2012","journal-title":"J Virol"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/JVI.02837-13","article-title":"Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6","volume":"88","author":"G Ofek","year":"2014","journal-title":"J Virol"},{"issue":"41","key":"ref26","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1016\/j.vaccine.2013.07.052","article-title":"A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants","volume":"31","author":"E Tumban","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1152\/physiol.00051.2010","article-title":"New insights into HIV assembly and trafficking","volume":"26","author":"M Balasubramaniam","year":"2011","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0092-8674(89)90873-8","article-title":"Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells","volume":"59","author":"D Gheysen","year":"1989","journal-title":"Cell"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/JVI.77.3.2081-2092.2003","article-title":"Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load","volume":"77","author":"MM Addo","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/rmv.449","article-title":"Virus-like particles as HIV-1 vaccines","volume":"15","author":"LX Doan","year":"2005","journal-title":"Rev Med Virol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/QAI.0b013e3181dc98a3","article-title":"Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV","volume":"54","author":"MD Hicar","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"13","key":"ref33","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1128\/JVI.75.13.5879-5890.2001","article-title":"Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques","volume":"75","author":"DC Montefiori","year":"2001","journal-title":"J Virol"},{"key":"ref34","first-page":"1","article-title":"Justification for the inclusion of Gag in HIV vaccine candidates","volume":"2015","author":"AL Williamson","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bcmd.2014.10.002","article-title":"Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease","volume":"54","author":"A Zimran","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11427-014-4746-7","article-title":"Fighting Ebola with ZMapp: spotlight on plant-made antibody","volume":"57","author":"Y Zhang","year":"2014","journal-title":"Science China Life sciences"},{"issue":"25","key":"ref37","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMoa1409838","article-title":"Clinical care of two patients with Ebola virus disease in the United States","volume":"371","author":"GM Lyon","year":"2014","journal-title":"N Engl J Med"},{"key":"ref38","article-title":"As Ebola Epidemic Begins to Slow, Trials of Drugs and Vaccines Speed Up","author":"BM Kuehn","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12985-014-0205-0","article-title":"Plant-based vaccines against viruses","volume":"11","author":"EP Rybicki","year":"2014","journal-title":"Virology journal"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/pbi.12058","article-title":"Biological and biochemical characterization of HIV-1 Gag\/dgp41 virus-like particles expressed in Nicotiana benthamiana","volume":"11","author":"SA Kessans","year":"2013","journal-title":"Plant Biotechnology Journal"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157016208784324994","article-title":"Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes","volume":"6","author":"N Matoba","year":"2008","journal-title":"Curr HIV Res"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bit.10012","article-title":"Expression of recombinant human acetylcholinesterase in transgenic tomato plants","volume":"75","author":"TS Mor","year":"2001","journal-title":"Biotechnol Bioeng"},{"key":"ref43","first-page":"102","article-title":"AVMA guidelines for the euthanasia of animals","author":"S Leary","year":"2013"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.4049\/jimmunol.0903346","article-title":"GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium","volume":"184","author":"R Shen","year":"2010","journal-title":"J Immunol"},{"issue":"22","key":"ref45","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"MB Zwick","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/mi.2009.89","article-title":"HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis","volume":"2","author":"D Tudor","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/QAD.0b013e32834507bd","article-title":"The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcgammaRI-dependent manner","volume":"25","author":"D Tudor","year":"2011","journal-title":"AIDS"},{"issue":"47","key":"ref48","doi-asserted-by":"crossref","first-page":"8542","DOI":"10.1016\/j.vaccine.2011.09.032","article-title":"Mucosal antibodies induced by tandem repeat of 2F5 epitope block transcytosis of HIV-1","volume":"29","author":"J Wang","year":"2011","journal-title":"Vaccine"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.vaccine.2012.01.026","article-title":"Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice","volume":"30","author":"M Zhou","year":"2012","journal-title":"Vaccine"},{"issue":"34","key":"ref50","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1016\/j.vaccine.2011.06.007","article-title":"Humoral immunogenicity of an HIV-1 envelope residue 649\u2013684 membrane-proximal region peptide fused to the plague antigen F1-V","volume":"29","author":"N Matoba","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.4049\/jimmunol.1300971","article-title":"Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses","volume":"191","author":"L Verkoczy","year":"2013","journal-title":"Journal of immunology"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2011.01.015","article-title":"Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges","volume":"34","author":"M Bomsel","year":"2011","journal-title":"Immunity"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1073\/pnas.0800255105","article-title":"A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies","volume":"105","author":"G Frey","year":"2008","journal-title":"P Natl Acad Sci USA"},{"issue":"6184","key":"ref54","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1126\/science.1254990","article-title":"AIDS\/HIV. Host controls of HIV neutralizing antibodies","volume":"344","author":"BF Haynes","year":"2014","journal-title":"Science"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"e0136507","DOI":"10.1371\/journal.pone.0136507","article-title":"Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion","volume":"10","author":"Z Gong","year":"2015","journal-title":"PLoS One"},{"issue":"47","key":"ref56","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1016\/j.vaccine.2007.09.016","article-title":"Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines","volume":"25","author":"J Hammonds","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1467-7652.2010.00507.x","article-title":"Plant-made vaccines for humans and animals","volume":"8","author":"EP Rybicki","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"7520","key":"ref58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"X Qiu","year":"2014","journal-title":"Nature"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"g5488","DOI":"10.1136\/bmj.g5488","article-title":"US signs contract with ZMapp maker to accelerate development of the Ebola drug","volume":"349","author":"M McCarthy","year":"2014","journal-title":"Bmj"},{"issue":"9","key":"ref60","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1073\/pnas.0409899102","article-title":"Immunogenicity in humans of an edible vaccine for hepatitis B","volume":"102","author":"Y Thanavala","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/bit.22299","article-title":"A DNA replicon system for rapid high-level production of virus-like particles in plants","volume":"103","author":"Z Huang","year":"2009","journal-title":"Biotechnology and bioengineering"},{"issue":"15","key":"ref62","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2008.01.053","article-title":"An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles","volume":"26","author":"L Santi","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1467-7652.2006.00191.x","article-title":"Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein","volume":"4","author":"X Zhang","year":"2006","journal-title":"Plant biotechnology journal"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"MA D'Aoust","year":"2010","journal-title":"Plant biotechnology journal"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6750-8-53","article-title":"Expression of HIV-1 antigens in plants as potential subunit vaccines","volume":"8","author":"A Meyers","year":"2008","journal-title":"BMC Biotechnol"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00425-009-0898-2","article-title":"High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts","volume":"229","author":"N Scotti","year":"2009","journal-title":"Planta"},{"issue":"35","key":"ref67","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.vaccine.2008.06.059","article-title":"Immunogenicity and tolerance following HIV-1\/HBV plant-based oral vaccine administration","volume":"26","author":"D Guetard","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jviromet.2004.06.022","article-title":"Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector","volume":"121","author":"DM Perez-Filgueira","year":"2004","journal-title":"Journal of virological methods"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1467-7652.2011.00609.x","article-title":"Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice","volume":"9","author":"N Gonzalez-Rabade","year":"2011","journal-title":"Plant biotechnology journal"},{"issue":"11","key":"ref70","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1600-0463.2008.00900.x","article-title":"Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses","volume":"116","author":"I Lindh","year":"2008","journal-title":"Apmis"},{"issue":"1\u20132","key":"ref71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-1759(98)00145-8","article-title":"Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization","volume":"220","author":"Z Durrani","year":"1998","journal-title":"J Immunol Methods"},{"issue":"18","key":"ref72","doi-asserted-by":"crossref","first-page":"8434","DOI":"10.1128\/JVI.75.18.8434-8439.2001","article-title":"Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1","volume":"75","author":"C Marusic","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1467-7652.2008.00381.x","article-title":"Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB MPR<sub>649 684<\/sub>","volume":"7","author":"N Matoba","year":"2009","journal-title":"Plant Biotechnol J"},{"issue":"11\u201312","key":"ref74","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0264-410X(98)00388-0","article-title":"Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide","volume":"17","author":"TL McInerney","year":"1999","journal-title":"Vaccine"},{"issue":"8","key":"ref75","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0264-410X(95)00229-T","article-title":"Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus","volume":"14","author":"L McLain","year":"1996","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T17:09:41Z","timestamp":1567703381000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151842"}},"subtitle":[],"editor":[{"given":"M. Lucrecia","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,17]]},"references-count":75,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151842","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,17]]}}}